Shankar Sumitra, Sreekumar Ahalya, Prasad Deepti, Das Ani V, Pillai M Radhakrishna
Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
Cancer Cell Int. 2018 Oct 22;18:169. doi: 10.1186/s12935-018-0666-0. eCollection 2018.
Gene knockout technologies involving programmable nucleases have been used to create knockouts in several applications. Gene editing using Zinc-finger nucleases (ZFNs), Transcription activator like effectors (TALEs) and CRISPR/Cas systems has been used to create changes in the genome in order to make it non-functional. In the present study, we have looked into the possibility of using six fingered CompoZr ZFN pair to target the E6 gene of HPV 16 genome.
HPV 16 cell lines; SiHa and CaSki were used for experiments. CompoZr ZFNs targeting E6 gene were designed and constructed by Sigma-Aldrich. TALENs targeting E6 and E7 genes were made using TALEN assembly kit. Gene editing was monitored by T7E1 mismatch nuclease and Nuclease resistance assays. Levels of E6 and E7 were further analyzed by RT-PCR, western blot as well as immunoflourescence analyses. To check if there is any interference due to methylation, cell lines were treated with sodium butyrate, and Nocodazole.
Although ZFN editing activity in yeast based MEL-I assay was high, it yielded very low activity in tumor cell lines; only 6% editing in CaSki and negligible activity in SiHa cell lines. Though editing efficiency was better in CaSki, no significant reduction in E6 protein levels was observed in immunocytochemical analysis. Further, in silico analysis of DNA binding prediction revealed that some of the ZFN modules bound to sequence that did not match the target sequence. Hence, alternate ZFN pairs for E6 and E7 were not synthesized since no further active sites could be identified by in silico analyses. Then we designed TALENs to target E6 and E7 gene. TALENs designed to target E7 gene led to reduction of E7 levels in CaSki and SiHa cervical cancer cell lines. However, TALEN designed to target E6 gene did not yield any editing activity.
Our study highlights that designed nucleases intended to obtain bulk effect should have a reasonable editing activity which reflects phenotypically as well. Nucleases with low editing efficiency, intended for generation of knockout cell lines nucleases could be obtained by single cell cloning. This could serve as a criterion for designing ZFNs and TALENs.
涉及可编程核酸酶的基因敲除技术已被用于多种应用中创建基因敲除。使用锌指核酸酶(ZFN)、转录激活样效应因子(TALE)和CRISPR/Cas系统进行基因编辑已被用于改变基因组,使其失去功能。在本研究中,我们探讨了使用六指CompoZr ZFN对靶向人乳头瘤病毒16型(HPV 16)基因组E6基因的可能性。
使用HPV 16细胞系SiHa和CaSki进行实验。由Sigma-Aldrich公司设计并构建靶向E6基因的CompoZr ZFN。使用TALEN组装试剂盒制备靶向E6和E7基因的TALEN。通过T7E1错配核酸酶和核酸酶抗性分析监测基因编辑。通过逆转录聚合酶链反应(RT-PCR)、蛋白质免疫印迹以及免疫荧光分析进一步分析E6和E7的水平。为检查是否存在甲基化干扰,用丁酸钠和诺考达唑处理细胞系。
尽管基于酵母的MEL-I分析中ZFN编辑活性很高,但在肿瘤细胞系中其活性很低;在CaSki细胞系中只有6%的编辑,在SiHa细胞系中活性可忽略不计。尽管CaSki细胞系中的编辑效率更高,但免疫细胞化学分析未观察到E6蛋白水平有显著降低。此外,DNA结合预测的计算机分析表明,一些ZFN模块与不匹配靶序列的序列结合。因此,由于计算机分析未鉴定出更多活性位点,未合成针对E6和E7的替代ZFN对。然后我们设计TALEN靶向E6和E7基因。设计靶向E7基因的TALEN导致CaSki和SiHa宫颈癌细胞系中E7水平降低。然而,设计靶向E6基因的TALEN未产生任何编辑活性。
我们的研究强调,旨在获得整体效应的设计核酸酶应具有合理的编辑活性,这在表型上也应有所体现。对于旨在生成基因敲除细胞系的低编辑效率核酸酶,可通过单细胞克隆获得。这可作为设计ZFN和TALEN的一个标准。